Tuesday, July 28, 2026
Researcher GPS
Issue No. 31

Where are you in the work?

Press Enter to set course · Escape to close

Chapter 5 · On the Day After a Rejection · 4 min read

ERK/GATAD2A/SAA1 axis drives osimertinib resistance via NF-κB and macrophage reprogramming in EGFR-mutated lung adenocarcinoma

Journal of Experimental & Clinical Cancer Research
Medicine
Publisher Journal of Experimental & Clinical Cancer Research
ISSN 10.1186/s13046-026-03792-6
Source CrossRef

Scope & Focus

Medicine

About This Journal

Authors: Junkan Zhu, Shencheng Ren, Tao Cheng, Guangyao Shan et al.

DOI: 10.1186/s13046-026-03792-6

Ready to Submit?

You will be directed to the journal website where you can review submission guidelines and submit your manuscript.

Visit Journal Website →